register

Digital & Innovation

CSIRO discussion paper on the ethics of AI

Health Industry Hub | April 16, 2019 |

Artificial Intelligence (AI) has the potential to provide social, economic, and environmental benefits. For Australia to realise these benefits, it’s important for citizens to have trust in how AI is being designed, developed and used by business and government.

The CSIRO are seeking your views on a discussion paper to inform the Government’s approach to AI ethics in Australia. The discussion paper was developed by CSIRO’s Data61 and designed to encourage conversations about AI ethics in Australia.

The paper and your feedback will help the CSIRO ensure AI is developed and applied responsibly in Australia.

The Ethics Framework research was funded by the government in the 2018 May Budget. The work was guided by a steering committee of experts from industry, government and community organisations as well as researchers from CSIRO and Data61. Consultative workshops were also held in Sydney, Brisbane, Melbourne and Perth during 2018.


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.